塔塔盒结合蛋白相关因子15作为胃肠道瘤的新潜在标记物
1Department of Pathology, Akdeniz University Medical School, Antalya 07070, Türkiye. elpek@akdeniz.edu.tr.
World journal of gastroenterology
|August 2, 2024
概括
塔塔盒结合蛋白相关因子15 (TAF15) 在胃肠 (GI) 癌症的发展和行为中起作用. TAF15可以作为治疗瘤的治疗标和生物标记物,特别是那些抵抗治疗的瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- TAF15是一种FET蛋白家族成员,参与各种细胞过程.
- TAF15与多种癌症类型的发病和进展有关.
- 它与MAPK信号通路的关联表明了治疗潜力.
研究的目的:
- 讨论TAF15在胃肠道 (GI) 癌症中的瘤发生和瘤行为的作用.
- 评估TAF15作为潜在的治疗标和GI恶性瘤中的生物标志物.
- 为了将这些角色与郭等人最近的发现联系起来.
主要方法:
- 文献审查和对TAF15现有研究的讨论15.
- 对TAF15参与致癌和瘤行为的分析.
- 探索TAF15与MAPK信号通路之间的联系.
主要成果:
- TAF15的表达与胃肠道癌的瘤攻击性行为有关.
- TAF15影响MAPK信号通路,这是癌症的一个关键通路.
- 在肠道系统中TAF15表达的有限研究存在潜在的局限性.
结论:
- TAF15作为预测胃肠道瘤行为的分子生物标志物具有前途.
- TAF15代表了肠道癌的潜在治疗标.
- 需要进一步的研究来阐明TAF15在肠道瘤中的预后和治疗意义,特别是在耐治疗病例中.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Serum Laboratory Studies, Stool Test, Breath Test
325
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
325


